SG Americas Securities’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-32,566
| Closed | -$509K | – | 2544 |
|
|
2025
Q1 | $509K | Sell |
32,566
-15,521
| -32% | -$243K | ﹤0.01% | 1575 |
|
|
2024
Q4 | $670K | Buy |
48,087
+9,754
| +25% | +$136K | ﹤0.01% | 953 |
|
|
2024
Q3 | $356K | Sell |
38,333
-60,828
| -61% | -$565K | ﹤0.01% | 1765 |
|
|
2024
Q2 | $922K | Buy |
99,161
+83,452
| +531% | +$776K | 0.01% | 1234 |
|
|
2024
Q1 | $156K | Sell |
15,709
-8,647
| -36% | -$85.9K | ﹤0.01% | 1928 |
|
|
2023
Q4 | $79K | Buy |
+24,356
| New | +$79K | ﹤0.01% | 2577 |
|
|
2023
Q3 | – | Sell |
-28,414
| Closed | -$271K | – | 2742 |
|
|
2023
Q2 | $271K | Buy |
28,414
+2,932
| +12% | +$28K | ﹤0.01% | 1454 |
|
|
2023
Q1 | $280K | Buy |
+25,482
| New | +$280K | ﹤0.01% | 1981 |
|
|
2022
Q4 | – | Sell |
-11,296
| Closed | -$216K | – | 2701 |
|
|
2022
Q3 | $216K | Sell |
11,296
-2,350
| -17% | -$44.9K | ﹤0.01% | 2007 |
|
|
2022
Q2 | $291K | Buy |
+13,646
| New | +$291K | ﹤0.01% | 2180 |
|
|
2022
Q1 | – | Sell |
-8,251
| Closed | -$171K | – | 2577 |
|
|
2021
Q4 | $171K | Sell |
8,251
-11,532
| -58% | -$239K | ﹤0.01% | 2477 |
|
|
2021
Q3 | $473K | Sell |
19,783
-5,065
| -20% | -$121K | ﹤0.01% | 2358 |
|
|
2021
Q2 | $678K | Buy |
24,848
+2,066
| +9% | +$56.4K | ﹤0.01% | 1618 |
|
|
2021
Q1 | $659K | Buy |
+22,782
| New | +$659K | ﹤0.01% | 1651 |
|
|
2020
Q3 | – | Sell |
-8,142
| Closed | -$246K | – | 2176 |
|
|
2020
Q2 | $246K | Buy |
8,142
+4,456
| +121% | +$135K | ﹤0.01% | 2309 |
|
|
2020
Q1 | $110K | Buy |
+3,686
| New | +$110K | ﹤0.01% | 2482 |
|